The tumor-educated-macrophage increase of malignancy of human pancreatic cancer is prevented by zoledronic acid

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Hiroshima, Yukihiko ^a,b,c   Maawy, Ali ^b   Hassanein, Mohamed K ^a,b   Menen, Rhiana ^a   Momiyama, Masashi ^c   Murakami, Takashi ^c   Miwa, Shinji ^a,b   Yamamoto, Mako ^a,b   Uehara, Fuminari ^a,b   Yano, Shuya ^a,b   Mori, Ryutaro ^c   Matsuyama, Ryusei ^c   Chishima, Takashi ^c   Tanaka, Kuniya ^c   Ichikawa, Yasushi ^c   Bouvet, Michael ^b   Endo, Itaru ^c   Hoffman, Robert M ^a,b  

^a ANTICANCER INC   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; IMIDAZOLE DERIVATIVE; ZOLEDRONIC ACID;

ANIMAL; CELL COMMUNICATION; CELL PROLIFERATION; DISEASE COURSE; DISEASE MODEL; DRUG EFFECTS; HUMAN; IMMUNOLOGY; MACROPHAGE; MITOSIS; MOUSE; PANCREAS TUMOR; PATHOLOGY; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; CELL COMMUNICATION; CELL LINE, TUMOR; CELL PROLIFERATION; DIPHOSPHONATES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HETEROGRAFTS; HUMANS; IMIDAZOLES; MACROPHAGES; MICE; MITOSIS; PANCREATIC NEOPLASMS;

EID: 84905909645     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103382     Document Type: Article

References (37)

1. Bouvet M, Tsuji K, Yang M, Jiang P, Moossa AR, et al. (2006) In vivo colorcoded imaging of the interaction of colon cancer cells and splenocytes in the formation of liver metastases. Cancer Res 66: 11293-11297. (Pubitemid 46009959)
2. Hoffman RM. (1999) Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic. Investigational New Drugs 17: 343-359.
3. Fu X, Besterman J., Monosov A, Hoffman RM. (1991) Models of human metastatic colon cancer in nude mice orthotopically constructed by using histologically intact patient specimens. Proc Natl Acad Sci USA 88: 9345-9349. (Pubitemid 21915628)
4. Kurahara H, Shinchi H, Mataki Y, Maemura K, Noma H, et al. (2011) Significance of M2-polarized tumor-associated macrophage in pancreatic cancer. J Surg Res 167: e211-9.
5. Rogers TL, Holen I. (2011) Tumour macrophages as potential targets of bisphosphonates. J Transl Med 9: 177.
6. Lee CH, Espinosa I, Vrijaldenhoven S, Subramanian S, Montgomery KD, et al. (2008) Prognostic significance of macrophage infiltration in leiomyosarcomas. Clin. Cancer Res 14: 1423-1430. (Pubitemid 351413925)
7. Zeisberger SM, Odermatt B, Marty C, Zehnder-Fjallman AH, Ballmer-Hofer K, et al. (2006) Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach. Br J Cancer 95: 272-281. (Pubitemid 44187587)
8. Menen RS, Hassanein MK, Momiyama M, Suetsugu A, Moossa AR, et al. (2012) Tumor-educated macrophages promote tumor growth and peritoneal metastasis in an orthotopic nude mouse model of human pancreatic cancer. In Vivo 26: 565-569.
9. Amoh Y, Nagakura C, Maitra A, Moossa AR, Katsuoka K, et al. (2006) Dual-color imaging of nascent angiogenesis and its inhibition in liver metastases of pancreatic cancer. Anticancer Research 26: 3237-3242. (Pubitemid 44701491)
10. McElroy M, Kaushal S, Tran Cao HS, Moossa AR, Talamini MA, et al. (2009) Upregulation of thrombospondin-1 and angiogenesis in an aggressive human pancreatic cancer cell line selected for high metastasis. Mol Cancer Therap 8: 1779-1786.
11. Tran Cao HS, Reynoso J, Yang M, Kimura H, Kaushal S, et al. (2009) Development of the transgenic cyan fluorescent protein (CFP)-expressing nude mouse for "Technicolor" cancer imaging. J. Cell. Biochem 107: 328-334.
12. Snyder CS, Kaushal S, Kono Y, Tran Cao HS, Hoffman RM, et al. (2009) Complementarity of ultrasound and fluorescence imaging in an orthotopic mouse model of pancreatic cancer. BMC Cancer 9: 106.
13. Nagakura C, Hayashi K, Zhao M, Yamauchi K, Yamamoto N, et al. (2009) Efficacy of a genetically-modified Salmonella typhimurium in an orthotopic human pancreatic cancer in nude mice. Anticancer Res 29: 1873-1878.
14. Murphy EA, Shields DJ, Stoletov K, Dneprovskaia E, McElroy M, et al. (2010) Disruption of angiogenesis and tumor growth with an orally active drug that stabilizes the inactive state of PDGFRb/B-RAF. Proc Natl Acad Sci USA 107: 4299-4304.
15. Hassanein MK, Suetsugu A, Saji S, Moriwaki H, Bouvet M, et al. (2011) Stemlike and non-stem human pancreatic cancer cells distinguished by morphology and metastatic behavior. J Cell Biochem 112: 3549-3554.
16. Hiroshima Y, Zhao M, Zhang Y, Maawy A, Hassanein MK, et al. (2013) Comparison of efficacy of Salmonella typhimurium A1-R and chemotherapy on stem-like and non-stem human pancreatic cancer cells. Cell Cycle 12: 2774-2780.
17. Tsuji K, Yang M, Jiang P, Maitra A, Kaushal S, et al. (2006) Common bile duct injection as a novel method for establishing RFP-expressing human pancreatic cancer in nude mice. J Pancreas 7: 193-199.
18. Jiang P, Yamauchi K, Yang M, Tsuji K, Xu M, et al. (2006) Tumor cells genetically labeled with GFP in the nucleus and RFP in the cytoplasm for imaging cellular dynamics. Cell Cycle 5: 1198-1201. (Pubitemid 43845380)
19. McElroy M, Kaushal S, Bouvet M, Hoffman RM. (2008) Color-coded imaging of splenocyte-pancreatic cancer cell interactions in the tumor microenvironment. Cell Cycle 7: 2916-2921.
20. Okabe M, Ikawa M, Kominami K, Nakanishi T, Nishimune Y. (1997) "Green mice" as a source of ubiquitous green cells. FEBS Lett 407: 313-319. (Pubitemid 27199450)
21. Yang M, Reynoso J, Jiang P, Li L, Moossa AR, et al. (2004) Transgenic nude mouse with ubiquitous green fluorescent protein expression as a host for human tumors. Cancer Res 64: 8651-8656. (Pubitemid 39552079)
22. Tran Cao HS, Kimura H, Kaushal S, Snyder CS, Reynoso J, et al. (2009) The cyan fluorescent protein (CFP) transgenic mouse as a model for imaging pancreatic exocrine cells. J Pancreas 10:152-156.
23. Yang M, Reynoso J, Bouvet M, Hoffman RM. (2009) A transgenic red fluorescent protein-expressing nude mouse for color-coded imaging of the tumor microenvironment. J Cell Biochem 106: 279-284.
24. Yamauchi K, Yang M, Jiang P, Xu M, Yamamoto N, et al. (2006) Development of real-time subcellular dynamic multicolor imaging of cancer-cell trafficking in live mice with a variable-magnification whole-mouse imaging system. Cancer Res 66: 4208-4214.
25. Yamauchi K, Tome Y, Yamamoto N, Hayashi K, Kimura H, et al. (2012) Color-coded real-time subcellular fluorescence imaging of the interaction between cancer and host cells in live mice. Anticancer Res 32: 39-43.
26. Uchugonova A, Hoffman RM, Weinigel M, Koenig K. (2011) Watching stem cells in the skin of living mice noninvasively. Cell Cycle 10: 2017-2020.
27. Fu X, Guadagni F, Hoffman RM. (1992) A metastatic nude-mouse model of human pancreatic cancer constructed orthotopically from histologically intact patient specimens. Proc Natl Acad Sci USA 89: 5645-5649.
28. Furukawa T, Kubota T, Watanabe M, Kitajima M, Hoffman RM. (1993) A novel "patient-like" treatment model of human pancreatic cancer constructed using orthotopic transplantation of histologically intact human tumor tissue in nude mice. Cancer Res 53: 3070-3072. (Pubitemid 23210314)
29. Bouvet M, Wang J-W, Nardin SR, Nassirpour R, Yang M, et al. (2002) Realtime optical imaging of primary tumor growth and multiple metastatic events in a pancreatic cancer orthotopic model. Cancer Res 62: 1534-1540. (Pubitemid 34407819)
30. Zhang W, Zhu XD, Sun HC, Xiong YQ, Zhuang PY, et al. (2010) Depletion of tumor-associated macrophages enhances the effect of sorafenib in metastatic liver cancer models by antimetastatic and antiangiogenic effects. Clin. Cancer Res 16: 3420-3430.
31. Baay M, Brouwer A, Pauwels P, Peeters M, Lardon F. (2011) Tumor cells and tumor-associated macrophages: secreted proteins as potential targets for therapy. Clin Dev Immunol 2011: 565187.
32. Karnevi E, Andersson R, Rosendahl AH. (2014) Tumour-educated macrophages display a mixed polarisation and enhance pancreatic cancer cell invasion. Immunol Cell Biol 2014, doi: 10.1038/icb.2014.22. [Epub ahead of print].
33. Rietkötter E, Menck K, Bleckmann A, Farhat K, Schaffrinski M, et al. (2013) Zoledronic acid inhibits macrophage/microglia-assisted breast cancer cell invasion. Oncotarget 4:1449-1460.
34. Rogers TL, Wind N, Hughes R, Nutter F, Brown HK, et al. (2013) Macrophages as potential targets for zoledronic acid outside the skeletonevidence from in vitro and in vivo models. Cell Oncol (Dordr) 36:505-514.
35. Märten A, Lilienfeld-Toal MV, Büchler MW, Schmidt J. (2007) Zoledronic acid has direct antiproliferative and antimetastatic effect on pancreatic carcinoma cells and acts as an antigen for delta2 gamma/delta T cells. J Immunother 30:370-377. (Pubitemid 46684427)
36. Hoffman RM, Yang M. (2006) Subcellular imaging in the live mouse. Nature Protocols 1:775-782.
37. Rogers TL, Holen I. (2011) Tumour macrophages as potential targets of bisphosphonates. J Transl Med 9:177.